Next |
home / stock / oncy / oncy message board
Subject | By | Source | When |
---|---|---|---|
Next stop $3.00 then $4.00 then its pretty | accipiterr | investorshub | 06/22/2023 3:45:38 PM |
Also Phase 1 Clinical trials for viral loaded | accipiterr | investorshub | 06/22/2023 3:24:46 PM |
$ONCY IS A PHASE 3 BIOTECH COMPANY WITH | accipiterr | investorshub | 06/22/2023 3:20:16 PM |
I am here. Here is a comment for | accipiterr | investorshub | 06/22/2023 3:08:51 PM |
NEWS -- Oncolytics Biotech's® Pelareorep Selected for Inclusion | Paulness | investorshub | 06/22/2023 1:39:57 PM |
$ONCY got some short data | Paulness | investorshub | 06/19/2023 12:28:06 AM |
$ONCY should we be shorting? | Selain7 | investorshub | 06/16/2023 10:48:24 PM |
$ONCY Anyone hear anything lately? Want to see this one go | Cobra Stock Sleuth | investorshub | 06/16/2023 2:49:59 AM |
$ONCY and the shorts continue | Paulness | investorshub | 06/15/2023 2:51:57 AM |
Bristol-Myers Squibb news coming !!!!!!!!!!!!!!! | Paulness | investorshub | 06/06/2023 12:41:58 AM |
NEWS -- Oncolytics Biotech Announces Updated Randomized Phase | Paulness | investorshub | 06/05/2023 12:55:31 PM |
what does this mean? | Paulness | investorshub | 06/04/2023 10:08:02 PM |
When is this gonna take off? | Paulness | investorshub | 06/04/2023 4:47:39 PM |
$ONCY what do you make of this data? | Paulness | investorshub | 06/04/2023 6:57:52 AM |
$ONCY and the shorts continue | Paulness | investorshub | 06/02/2023 11:42:19 PM |
what do you make of this data? | KngmAz | investorshub | 06/01/2023 7:37:14 PM |
The trading | tknuncle | investorshub | 05/31/2023 8:05:46 PM |
$ONCY MomentumIts trading | Paulness | investorshub | 05/31/2023 1:29:48 PM |
great news | Cobra Stock Sleuth | investorshub | 05/31/2023 8:34:33 AM |
$ONCY short squeeze signal | 1984ISHERE | investorshub | 05/28/2023 12:02:50 AM |
News, Short Squeeze, Breakout and More Instantly...
Oncolytics Biotech Inc. Company Name:
ONCY Stock Symbol:
NASDAQ Market:
Oncolytics Biotech Inc. Website:
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA Canada NewsWire Requested for Q2 2024, the Type C meeting is to focus on planned registration-enabling trial in HR+/HER2- metas...
USA News Group – Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate of all major cancers today. However, researchers and the biotech sector are working diligently to improve the chances of those who receive this dire diagnosis. Rec...
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights Canada NewsWire Pelareorep advancing to a registration-enabling study in 2024 in pancreatic cancer and expands pancreatic potential with new GOBLET cohort in combina...